“In the U.S., clinical genetic and genomic testing labs provide diagnostic, predictive, prognostic, and theragnostic tests with perceived clinical value—a perception is frequently untethered from reality. This means that many patients are inadvertently harmed when well-meaning clinicians use low-value and inaccurate tests in patient care.”
Recent Posts
- Jan/Feb 2023 – The Data Driven Point of View
- The Business of Labs Negatively Impacts the Potential Outcomes for Patients
- December 2022 – The Data Driven Point of View
- Congress Needs to Update FDA’s Ability to Regulate Diagnostic Tests, Cosmetics
- Disagreement in Clinical Genetics Could Determine a Mother’s Freedom
Recent Comments